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Abstract
Background: Endemic presence of Klebsiella pneumoniae resistant to carbapenem in Italy has been due principally
to the clonal expansion of CC258 isolates; however, recent studies suggest an ongoing epidemiological change in
this geographical area.
Methods: 50 K. pneumoniae strains, 25 carbapenem-resistant (CR-Kp) and 25 susceptible (CS-Kp), collected from
march 2014 to march 2016 at the Laboratory of Bacteriology of the Paolo Giaccone Polyclinic University hospital of
Palermo, Italy, were characterized for antibiotic susceptibility and fully sequenced by next generation sequencing
(NGS) for the in silico analysis of resistome, virulome, multi-locus sequence typing (MLST) and core single
nucleotide polymorphism (SNP) genotypes
Results: MLST in silico analysis of CR-Kp showed that 52% of isolates belonged to CC258, followed by ST395 (12%),
ST307 (12%), ST392 (8%), ST348 (8%), ST405 (4%) and ST101 (4%). In the CS-Kp group, the most represented isolate
was ST405 (20%), followed by ST392 and ST15 (12%), ST395, ST307 and ST1727 (8%). The in silico β-lactamase
analysis of the CR-Kp group showed that the most detected gene was blaSHV (100%), followed by blaTEM (92%),
blaKPC (88%), blaOXA (88%) and blaCTX-M (32%). The virulome analysis detected mrk operon in all studied isolates,
and wzi-2 was found in three CR-Kp isolates (12%). Furthermore, the distribution of virulence genes encoding for
the yersiniabactin system, its receptor fyuA and the aerobactin system did not show significant distribution
differences between CR-Kp and CS-Kp, whereas the Klebsiella ferrous iron uptake system (kfuA, kfuB and kfuC genes),
the two-component system kvgAS and the microcin E495 were significantly (p < 0.05) prevalent in the CS-Kp group
compared to the CR-Kp group.
Core SNP genotyping, correlating with the MLST data, allowed greater strain tracking and discrimination than MLST
analysis.
Conclusions: Our data support the idea that an epidemiological change is ongoing in the Palermo area (Sicily,
Italy). In addition, our analysis revealed the co-existence of antibiotic resistance and virulence factors in CR-Kp
isolates; this characteristic should be considered for future genomic surveillance studies.
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Background
The World Health Organization (WHO), the US Centers
for Disease Control and Prevention (CDC) and the UK
Department of Health have indicated Klebsiella pneumo-
niae as one of the multi drug resistant (MDR) microor-
ganisms constituting an immediate threat for human
health [1–3]. K. pneumoniae, an opportunistic pathogen,
has emerged not only thanks to its ability to accumulate
multiclass antibiotic resistance determinants over time
[1] but also, as widely reported, to its adeptness in caus-
ing severe community- and hospital-associated infec-
tions [4–6].
K. pneumoniae “permeability” to mobile genetic ele-
ments is a key factor for its dissemination not only with
respect to the possibility of becoming resistant to antibi-
otics, but also of evolving towards more virulent pheno-
types thanks to genes that may provide a survival benefit
to microorganisms [7, 8]. However, in K. pneumoniae the
relation between resistance and virulence is a complex
issue since a systematic understanding of its population
structure is still lacking [4, 9]. This makes it difficult to
perceive the emergence of new clones, what instead could
be an advantageous approach to develop epidemiological
surveillance programs and avoid outbreaks, particularly of
strains which have become resistant to carbapenem (car-
bapenem-resistant K. pneumoniae, CR-Kp) [9–11].
The existing body of research on carbapenem-
resistance mechanisms suggests that the production of
K. pneumoniae carbapenemase (KPC) encoded by the
plasmidic gene blaKPC is the most common one and
its rapid dissemination has typically been caused by
the clonal expansion of clonal complex (CC) 258
strains, including ST258 and ST512 [12–16]. In Italy,
the first KPC-positive K. pneumoniae, belonging to
ST258, was isolated in Florence in 2008 [17]. Since
then, the diffusion of these strains has been evident.
In fact, the last European Antimicrobial Resistance
Surveillance Network report has confirmed an average
prevalence of CR-Kp of up to 33.9%, percentages that
make Italy an endemic country for this microorgan-
ism [18, 19].
To date, although some research has been carried out
on the diffusion and genetic characteristics of KPC-
positive K. pneumoniae in our region (Sicily, Italy), no sin-
gle study exists which has comprehensively described
these strains considering all of the Hospital’s Departments
for a period longer than 1 year [20–24].
In this study, we fully sequenced 50 K. pneumoniae
strains, both carbapenem resistant and -susceptible, col-
lected from March 2014 to March 2016 at the Labora-
tory of Bacteriology of the Department of Sciences for
Health Promotion and Mother-Child Care “G. D’Ales-
sandro” (Paolo Giaccone Polyclinic University Hospital,
University of Palermo, Italy).
The primary aim of this study was to take a current
snapshot of the distribution of K. pneumoniae in our
geographic area by: 1) characterizing the virulome and
resistome of CR-Kp clones; 2) assessing the extent to
which virulence determinants were carried by CR-Kp
and CS-Kp (carbapenem susceptible K. pneumoniae); 3)
investigating the phylogenetic correlations among sam-
ples by Multilocus sequence typing (MLST) in silico and
the analysis of core single nucleotide polymorphisms
(SNPs).
Methods
Bacterial strains and antimicrobial susceptibility testing
Species and antimicrobial susceptibility were determined
using the Becton- Dickinson Phoenix™ automated system
(Becton Dickinson, Sparks, MD, USA). Resistance to car-
bapenem was established by interpreting the results of
the antimicrobial susceptibility test on the basis of the
breakpoint criteria of the European Committee on Anti-
microbial Susceptibility Testing [25]. On the base of car-
bapenem susceptibility the 50 strains were divided in 25
isolates resistant (CR-Kp) and 25 sensitive (CS-Kp).
Table 1 shows the entire clinical sample and the depart-
ments of isolation.
DNA isolation
The template DNA was prepared from bacterial colonies
grown for 18 h on Blood Agar plates. Colonies were
picked and suspended in 500 μl of ultra-pure DNase-free
water. The suspension was harvested at 14000 rpm for
10min. The supernatants were discarded while DNA
from the pellets were extracted using the QIAmp® DNA
Mini kit Qiagen (QIAGEN; Hilden, Germany), the quan-
tity and purity of the DNA were determined using
NanoDrop 8000 spectrophotometer (Thermo Fisher Sci-
entific, Waltham).
Whole-genome sequencing
Isolate’s genomes were fully sequenced at the Scientific
Department, Army Medical Center, Military Polyclinic
of Rome (Italy) using the next-generation sequencing on
the Illumina MiSeq platform (San Diego, CA, USA) as
recommended by the manufacturer. The library sizes
had peaks centered from 900 to 1000 bp.
The reads were de novo assembled into contigs using
AByss, version 1.5.2 (k parameter = 63) [22]. Contigs lon-
ger than 500 bp were selected using an ad hoc script and
kept for further analysis. The final assembly ranged from
44 to 414 (median: 143) contigs per sample (N50: 335,
064–64,441; median: 111,289). Contigs were merged
through the Minimus2 software (Sommer et al., 2007)
and resulting DNA sequences were analysed for similar-
ity using the database sequences by the Standard Nu-
cleotide BLAST program (http://blast.ncbi.nlm.nih.gov/
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Table 1 K. pneumoniae CR and CS isolates, department of isolations, host disease, host age and clinical sample
CR-
Kp
ID
Department host disease host
age
Sample CS-
Kp
ID
Department host disease host
age
Sample
1 R General surgeries
emergencies
sepsi 70 Blood PVC 1 S Endocrinology and
Metabolic diseases
ICU 75 Urine
2 R Anaesthesia and
resuscitation
sepsi 46 Blood CVC 2 S Surgical Oncology ICU 81 Urine
3 R Anaesthesia and
resuscitation
sepsi 59 Blood PVC 3 S Nephrology and
Hypertension
ICU 70 Urine
4 R Anaesthesia and
resuscitation
pneumoniae 60 Bronchoalveolar
lavage
4 S Clinical Respiratory Medicine ICU 64 Urine
5 R General surgeries
emergencies
sepsi 36 Intra-abdominal
fluid
5 S General and Thoracic
Surgery
ICU 52 Wound swab
6 R Internal Medicine
Cardioangiology
sepsi 36 Blood PVC 6 S Geriatric medicine infected
wound
21 Urine
7 R Cardiac surgery sepsi 53 Blood CVC 7 S Geriatric medicine ICU 82 Ulcer swab
8 R Clinical Respiratory
Medicine
ICU 77 Urine 8 S Plastic surgery infected
wound
82 Tissue
9 R Internal Medicine ICU 49 Urine 9 S Clinical Respiratory Medicine infected
wound
74 Urine
10 R Clinical Respiratory
Medicine
ICU 79 Urine 10 S Internal Medicine
Cardioangiology
ICU 76 Sputum
11 R Geriatric medicine ICU 90 Urine 11 S Infectious disease pneumoniae 77 Sputum
12 R Endocrinology and
Metabolic diseases
ICU 84 Urine 12 S Clinical Respiratory Medicine pneumoniae 22 Bronchoalveolar
lavage
13 R Anaesthesia and
resuscitation
sepsi 70 Blood PVC 13 S NICU pneumoniae 81 Endotracheal
tube
14 R Internal Medicine
Cardioangiology
sepsi 54 CVC 14 S Haematology and Bone
Marrow Transplantation
pneumoniae 15
days
Sputum
15 R Cardiac surgery pneumoniae 72 Bronchoalveolar
lavage
15 S Rheumatology pneumoniae 83 Urine
16 R Anaesthesia and
resuscitation
ICU 60 Urine 16 S Internal Medicine ICU 73 Sputum
17 R Internal Medicine
Cardioangiology
infected
wound
38 Ulcer swab 17 S Geriatric medicine pneumoniae 76 Urine
18 R Internal Medicine
Cardioangiology
pneumoniae 77 Sputum 18 S Rheumatology ICU 36 Urine
19R Cardiac surgery infected
wound
71 Wound swab 19 S Clinical Respiratory Medicine ICU 91 Sputum
20 R Clinical Respiratory
Medicine
ICU 80 Urine 20 S General surgeries
emergencies
pneumoniae 63 Liquor
21 R General surgeries
emergencies
bile
infections
65 Bile 21 S Internal Medicine
Cardioangiology
Meningitidis 92 Urine
22 R Anaesthesia and
resuscitation
sepsi 70 Blood CVC 22 S Anaesthesia and resuscitation ICU 82 Urine
23 R Cardiac surgery pneumoniae 62 Sputum 23 S Haematology and Bone
Marrow Transplantation
ICU 70 Cutaneous swab
24R General surgeries
emergencies
sepsi 72 Intra-abdominal
fluid
24 S Tourism and Migration infected
wound
81 Urine
25 R General surgeries
emergencies
sepsi 54 Abscess fluid 25 S Internal Medicine
Cardioangiology
ICU 71 Urine
CVC: central venous catheter, ICU: intensive care unit, NICU: neonatal intensive care unit, PVC: Peripheral venous catheter
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Blast.cgi). Illumina-generated sequence data for the
whole data set of this study have been deposited at NCBI
(BioProject id: PRJNA515715 and accession number
SUB5047324).
Analysis of virulome and resistome
Virulome of all K. pneumoniae sample was analysed using
the VirulenceFinder-1.4 tool and the Pasteur K. pneumo-
niae database. The resistome of carbapenem-resistant K.
pneumoniae was analysed using the ResFinder-2.1 soft-
ware (default identity thresholds [ID] 98%) which was pro-
vided by the Center for Genomic Epidemiology (http://
www.genomicepidemiology.org) and the resources of the
Pasteur MLST K. pneumoniae database.
Multilocus sequence typing (MLST) in silico
he in silico MLST analysis was made by comparing
the whole-genome sequences against the K. pneumo-
niae alleles profiles available at http://www.pasteur.
fr/mlst (Genotyping of Pathogens and Public Health,
Institute Pasteur, Paris, France).
Core single-nucleotide polymorphisms (SNPs)
Phylogenetic analysis based on genome-wide single nu-
cleotide polymorphisms (SNPs) were conducted detecting
SNPs through the kSNP v2.1.2 program (k-mer = 21),
which defines a SNP locus as an oligo of length k sur-
rounding a central SNP allele [26]. Maximum likelihood
tree based on the 57,766 core SNPs identified by kSNP
program was visualised using the Dendroscope v3.2.10
software [27]. Strain 8S, K. pseudopneumoniae, was used
as outgroup to root the tree.
Statistical analysis
Data were expressed as absolute numbers or percentages.
The Chi-squared test was used to compare proportions (as
appropriate). Values of p < 0.05 were considered statistically
significant. The statistical analysis were performed with Med-
Calc Statistical software version 16.8 (MedCalc Software
bvba, Ostend, Belgium; https://www.medcalc.org; 2016).
Results
CR-Kp were mainly isolated from blood and urinary
samples (28% for both) (Fig. 1), while the ward from
which CR-Kp was primarily isolated was the Anaes-
thesia and Resuscitation Department (24%) (Table 1).
Regarding CS-Kp, urines were the major isolation
sample (52%) (Fig. 1), while the ward from which
CS-Kp was primarily isolated was the Respiratory
Department (52%) (Table 1).
Antibiotic resistance
The percentages of antibiotic resistance among K. pneumo-
niae carbapenem-resistant and carbapenem-susceptible
strains are reported in Table 2. As shown, the CR-Kp group
displayed a higher percentage of resistance for all tested an-
tibiotics compared to the susceptible group. Statistical sig-
nificance was calculated where applicable. In particular,
20% of CR-Kp and 4% of CS-Kp were colistin-resistant.
Complete antibiotic resistance profile of CR-Kp are shown
in Additional file 1.
MLST analysis and Core single-nucleotide polymorphisms
(SNPs) phylogenetic analysis
MLST in silico analysis of CR-Kp revealed that 52%
belonged to CC258. In particular, 5 strains were ST258
(20%) and 8 were ST512 (32%). The remaining 12 strains
Fig. 1 Samples from where isolated the strains
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Table 2 Percentage of antibiotic resistance in carbapenem resistant and susceptible K. pneumoniae
Class Antibiotics K. pneumoniae CR % K. pneumoniae CS % P value
Aminoglicosydes Gentamycin 64 48 0.022
Carbapenems Imipenem 100 0 NA
Meropenem 100 0 NA
Ertapenem 100 0 NA
Monobactams Aztreonam 100 60 NA
Fluoroquinolones Ciprofloxacin 100 64 NA
Sulfonamides-
Trimethoprim
Trimethoprim-sulfamethoxazole 76 60 0.015
Penicillin Amoxicillin/ clavulanic acid 100 56 NA
Piperacillin/tazobactam 100 44 NA
Cephalosporin Cefotaxime 100 60 NA
Cefuroxime 100 60 NA
Cefepime 88 56 0
Ceftazidime 100 60 NA
Fosfomycin c/G6P 36 16 0.001
Tetracyclin Tigecyclin 8 4 0.233
Colistin 20 4 0
NA: chi-squared test not applicable
Fig. 2 Percentage of ST found
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were distributed as follows: 3 were ST395 (12%), 3 were
ST307 (12%), 2 were ST392 (8%), 2 were ST348 (8%), 1
was ST405 (4%) and 1 was ST101 (4%). Among CS-Kp’s
we detected 14 different STs. ST405 was the most repre-
sented (5 strains, 20%), followed by ST392 and ST15 (3
strains, 12%), ST395, ST307 and ST1727 (2 strains, 8%),
and one strain each for all other STs. Figure 2 shows ST
distribution across the entire sample.
The core-SNP phylogenetic analysis showed that
strains belonging to the same ST clustered in the same
groups, without regard to CR susceptibility or resistance
(see Additional file 3). Moreover, the SNP analysis allows
distinguishing each different strain.
Virulome: CR-Kp group versus CS-Kp group
Virulence factors distribution in CR-Kp and CS-Kp is
detailed in Table 3. The mrk operon, which encodes type
3 fimbriae, was detected in all isolates. The wzi gene, in-
volved in the capsule attachment to the host cell surface
and used for the prediction of capsular (K) antigen type,
was found in all CR-Kp isolates (100%), in particular, 3
strains carried the wzi-2 allele (see Additional file 4). Re-
garding the iron acquisition systems, the distribution of
genes encoding for the yersiniabactin system (ybt), its re-
ceptor fyuA and the aerobactin system did not show sig-
nificant differences between CR-Kp and CS-Kp (Table
3). Klebsiella ferrous iron uptake system (kfuA, kfuB and
kfuC genes), the two-component system kvgAS and the
microcin E495 were significantly (p < 0.05) prevalent in
the CS-Kp group (28%) compared to the CR-Kp one
(4%) (Table 3).
Table 4 displays the comparative analysis of virulence
determinants between CR-Kp and CS-Kp belonging to
the same ST. All strains belonging to ST405, regardless
of their resistance profile, had the same determinants
(mrk, wzi-143, ybt, microcin E495 and kvgAS. Regarding
the strains belonging to ST307, both CR-Kp and CS-Kp
strains had the mrk operon, wzi-173 and ybt operon,
with the exception of the 5R isolate, lacking ybt genes
(Table 4).
Virulome subanalysis by STs across the CR-Kp group
CR-Kp isolates belonging to ST512, ST258 did not carry
virulence determinants other than mrk and wzi (Table
4). The three strains belonging to ST395 carried four
virulence determinants: mrk, fyuA/irp2, iucABCD and
wzi type 2. wzi gene type 27 was found in the two ST392
isolates together with the mrk operon. Strains belonging
to ST348 carried the mrk operon, ybt operon and wzi-94
gene, whereas the ST101 strain exhibited mrk, ybt op-
eron, wzi type 17 and the kfuABC system. The ST405
isolate was the only one that carried the kvgAS operon
and the microcin E495, together with the mrk operon,
ybt operon and the wzi-143.
Resistome analysis across the CR-Kp group
The in silico β-lactamase characterisation of CR-Kp isolates
showed that the most frequent carbapenemase-producing
gene was blaSHV (100%). In particular, SHV variant 182
was detected in 16 out of 25 isolates (64%), while variant 28
in four strains (16%), three ST307 and the only ST101 iso-
late. blaKPC was identified in 88% of isolates and the most
common variant was blaKPC-3 (90.9%). blaTEM was
found in 23 isolates (92%), all of which were variant 1 and
blaCTX-M (variant 15) was found in 8 isolates (32%).
blaOXA was found in 22 isolates (88%), 14 of these were
Table 3 Distribution of virulence factors in carbapenem resistant and susceptible K. pneumoniae strains
Virulence factors Locus-Genes K. pneumoniae CR
n (%)
K. pneumoniae CS
n (%)
P value
Type 3 fimbries mrk operon 25 (100%) 25 (100%) 1.000
Capsule wzi 25 (100%) 23 (92%) 0.552
Iron acquisition
systems
ybt operon 10 (40%) 15 (60%) 0.089
Aerobactin iron acquisition
siderophore
(iucABCD)
3 (12%) 3 (12%) 1.000
Klebsiella
Ferric ionic-uptake system
(kfuABC)
1 (4%) 7 (28%) 0.020
Two-component
system
kvgAS 1 (4%) 7 (28%) 0.020
Bacteriocin Microcin E492 1 (4%) 7 (28%) 0.020
Table 4 Distribution of virulence determinants in STs clone of K.
pneumoniae CR and CS
STs CR-Kp CS-Kp
ST395 mrk, wzi-2, ybt, yuc, mrk, wzi-2, ybt, yuc
ST307 mrk, wzi-173 ybt 1 mrk, wzi-173, ybt
ST392 mrk, wzi-187 mrk, wzi-187
ST405 mrk, wzi-143, ybt, kvgAS, E495 mrk, wzi-143, ybt, kvgAS, E495
1missing in one of the three CR isolates
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variant 9 (63.6%), 5 were variant 1 (22.72%) and 3 isolates
(13.63%) presented both variants, blaOXA-1 and blaOXA-
9. Five isolates, one belonging to ST395, two to ST307, one
to ST101 and one to ST405 owned all the five
carbapenemase-producing genes investigated (Table 5).
Complete data from the in silico analysis (e.g. encoding ef-
flux pumps, heavy metal resistance system, genes involved
in aminoglycoside and fluoroquinolone resistance) are
shown in Additional file 2.
Discussion
The epidemiology of CR-Kp in our geographic area (Pa-
lermo, Italy) has already been characterized in the late
2008 at the emergence of CR-Kp ST258 clones [20].
However, several reports have suggested an ongoing epi-
demiological change in the last years. In fact, whereas
CC258 (ST258 and ST512) is still prevalent, several
other STs are emerging and circulating [23, 24, 28].
This study set out with the aim of assessing the
current dissemination and genetic characteristics of K.
pneumoniae in Palermo. Even though a larger sample
may have allowed to gain more representative data, our
preliminary data reveal a complex situation character-
ized by: 1) high genome “plasticity” of both CR-Kp and
CS-Kp, due to the presence of several virulence and re-
sistance determinants carried by mobile genetic ele-
ments; 2) a CR-Kp group showing an important genetic
diversity of lineages, with 8 different STs identified; 3)
an overlapping of multi-drug resistance and hyper viru-
lence traits in the CR-Kp group.
Regarding STs, our comprehensive analysis indicates
that, although ST258 and ST512 remain the most repre-
sentative ones, other STs (e.g. ST307, ST395, ST392,
ST348, ST405 and ST101) have been detected in our
area. These results are consistent with the surveillance
data from other authors [20–24, 28]. Moreover, our
findings on β-lactamase characterisation showed that the
blaSHV gene was the most commonly found in our
sample, followed by blaTEM and blaKPC, deviating
from other studies [11, 29, 30], while respect to the
KPC-type enzyme our results are in line with those of
other studies - as the most commonly encountered is
Table 5 K. pneumoniae CR profile: colistin susceptibility, carbapenemase, ESBL and beta-lactamases genes
STs ID CS (mg/L) bla KPC bla SHV bla CTX-M bla TEM bla OXA
ST512 6 R <=1 3 182 – 1 9
7 R <=1 3 182 – 1 9
8 R <=1 3 182 – – –
11 R <=1 3 182 – 1 9
16 R <=1 3 182 – 1 9
19 R > 4 3 182 – – 1
22 R <=1 3 182 – 1 9
25 R <=1 3 182 – 1 9
ST258 12 R <=1 3 182 – 1 9
18 R <=1 3 182 – 1 9
21 R <=1 3 182 – 1 9
23 R > 4 3 182 – 1 9
24 R <=1 3 182 – 1 9
ST395 2 R <=1 3 182 – 1 –
4 R <=1 3 182 15 1 1
10 R <=1 3 182 – 1 –
ST307 5 R <=1 9 28 15 1 9
13 R <=1 3 28 15 1 1/9
20 R > 4 R 2 28 – 1 1/9
ST392 1 R <=1 3 67 15 1 9
3 R <=1 – 67 15 1 1
ST 348 15 R > 4 R – 81 15 1 1
17 R <=1 – 81 15 1 1
ST 101 9 R <=1 3 28 – 1 9
ST 405 14 R > 4 R 3 76 15 1 1/9
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blaKPC-3 [21, 23, 31–33]. Regarding STs, the most rep-
resented across the CR-Kp group were ST512 and
ST258. These isolates did not carry any distinguishing
virulence determinant (except for the mrk operon and
wzi gene, which were present in all the samples), sug-
gesting that the success of these clones may only depend
on the acquisition of the blaKPC gene [9, 15, 34].
Among the ST512 isolates, we found the 19R strain
profile to be particularly interesting. This colistin-
resistant strain was the only one in its ST group that
showed both the yersiniabactin system and its receptor,
which has been detected in several K. pneumoniae MDR
clones; despite of this, the clinical effect of the yersinia-
bactin system on CR-Kp infections has not been clearly
determined [4, 35, 36].
Our data also match those of reports suggesting the
recent spread of the well-known clone ST307. In fact,
in 2014, a CR-Kp ST307 clone carrying the blaKPC-3,
coproducing the blaCTX-M-15, has been isolated in
three Palermo’s Hospitals [23]. The virulome analysis of
our ST307 strains has revealed, that 5R isolate was the
only one missing the yersiniabactin locus in its ST
group. Furthermore, 13R and 5R isolates, two of the
three strains belonging to ST307, showed the co-
presence of all five carbapenem resistance genes ana-
lysed. The co-presence of the detected virulence factors
together with the MDR phenotype may explain the dif-
fusion of this clone and the severity of its infections,
which have been reported as characterised by higher
mortality rates (over 50%) compared to other clones
[37, 38]. Moreover, leaving aside specific considerations
about the clone ST307, the co-presence of five carba-
penem resistance genes that we detected in five strains
of our sample (20%) is in line with that of a study by
Ferreira et al., which has recently reported that 72% of
the K. pneumoniae isolated from a Brazilian Intensive
care Unite co-produced blaKPC, blaOXA, blaTEM,
blaSHV, and blaCTX-M [39].
Another emerging clone, already isolated by other au-
thors in Palermo and also detected in our CR-Kp sam-
ple, was the ST395 [40]. Strains belonging to this clone
presented the wzi2 allele, which encodes the type K2
capsular antigen that represents one of the most virulent
serotypes, thus defined “more virulent” [41, 42]. CR-Kp
ST395 strains also carried the yersiniabactin system and
its receptor and were the only resistant isolates to pos-
sess the aerobactin system (iucABCD). Two aspects of
these strains should be addressed here: i) 4R isolate
showed the co-presence of five carbapenem resistance
genes; ii) to the best of our knowledge, this is the first
time that a CR-Kp ST395 clone is reported as carrying a
type 2 capsule. This finding was unexpected and seems
to be in contrast with the concept that MDR and hyper
virulent clonal complexes do not normally overlap [42].
Moreover, our data confirm the spreading of the
ST392 clone. A recently published study by Di Mento
and colleagues has reported, for the first time, the isola-
tion of a K. pneumoniae strain ST392 blaKPC-3 carrying
the blaCTX-M-15, blaSHV-11 and blaTEM-1 genes
from a patient in Palermo who had undergone kidney-
pancreas transplantation [43]. In our CR-Kp ST392 sam-
ple, the 1R strain which was isolated from blood at the
General and Emergency Surgery Department in 2015,
showed the co-existence of blaKPC-3, blaSHV-67,
blaCTX-M-15, blaTEM-1 and blaOXA-9. This result is
interesting as the only other KPC-producing K. pneumo-
niae ST392 ever reported was isolated in China but with
a different isoform, KPC-2 [44]. However, it is important
to underline that the other ST392 strain (3R) in our CR-
Kp sample did not carry the blaKPC gene, suggesting
that the ST392 KPC-3 clone may have acquired the re-
sistance gene through horizontal transmission, as de-
scribed by other authors [43].
This study also revealed two MDR CR-Kps belonging
to ST348 and carrying the blaCTX-M-15, blaSHV-81,
blaTEM-1 and blaOXA-1 genes. Strains belonged to
ST348, but harboured the blaKPC-3, which had been
previously reported as responsible of several epidemic
events in Portugal [45]. Considering that one of our iso-
lates was colistin-resistant and the ease with which K.
pneumoniae acquires the blaKPC gene, we can consider
the MDR CR-Kp ST348 strains as possibly emerging
high-risk clones.
Three other important data that emerge from our re-
sults and complete the description of the CR-Kp epi-
demiological scene in Palermo are: firstly, the circulation
of strains belonging to ST101. This clone was previously
recognized worldwide as a high risk carbapenem-
producing clone [30] and has already been identified in
Palermo and in the North of Italy [46–48]. Our ST101
strain (9R) carried the blaKPC-3, blaSHV-28, blaTEM-1
and blaOXA-9 genes and the Klebsiella ferrous uptake
system, which is typically found in K. pneumoniae hyper-
virulent strains [49, 50]; secondly, the characteristic of the
strain belonging to ST405, which carried the blaKPC-3,
blaCTX-15, blaSHV-76, blaTEM-1 and blaOXA-1/9
genes, the aac6-Ib-cr and qnrB and was resistant to colis-
tin. Strains from ST405 have similarly caused an outbreak
in a Spanish Hospital neonatal unit [50] and have already
been isolated in Palermo [24]. It is important to underline
that the genes involved in microcin production and kvgA/
S system were detected in all isolates belonging to ST405,
both resistant and susceptible to carbapenem, possibly in-
dicating a stable and characteristic genetic pattern for
these clones; lastly to the best of our knowledge this is the
first study to report in Italy the isolation of five CR-Kp iso-
lates belonging to different STs showing the co-presence
of five carbapenem resistance genes.
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Conclusions
These results are significant in at least two major re-
spects. Overall, this study strengthens the idea that the
epidemiological frame in the Palermo area (Sicily, Italy)
is shifting and new MDR clones are emerging. However,
our analysis, which included the comparison of the viru-
lence degree of CS-Kp and CR-Kp isolates, has unex-
pectedly revealed that the latter are acquiring highly-
virulent determinants and the co-presence of more re-
sistance genes. Undoubtedly, since co-existence of anti-
biotic resistance and virulence factors may lead to life-
threatening untreatable and invasive K. pneumoniae in-
fections, this is an important issue to take into consider-
ation for future genomic surveillance studies.
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